Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

Raymond R. Tubbs; Hongwei Wang; Zhen Wang; Eugen C. Minca; Bryce P. Portier; Aaron M. Gruver; Christopher Lanigan; Yuling Luo; James R. Cook; Xiao Jun Ma

doi:10.1309/AJCPJTWK07FSABRJ

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

Raymond R. Tubbs, Hongwei Wang, Zhen Wang, Eugen C. Minca, Bryce P. Portier, Aaron M. Gruver, Christopher Lanigan, Yuling Luo, James R. Cook, Xiao Jun Ma

Academic Institute

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Objectives: To assess the feasibility of using a novel ultrasensitive bright-field in situ hybridization approach (BRISH) to evaluate k and l immunoglobulin messenger RNA (mRNA) expression in situ in B-cell non-Hodgkin lymphoma (NHL). Methods: A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH. Results: BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated. Conclusions: BRISH analysis of k and l immunoglobulin mRNA expression is a sensitive tool for establishing LCR in B-cell NHL when FCM results are not available.

Original language	English (US)
Pages (from-to)	736-746
Number of pages	11
Journal	American Journal of Clinical Pathology
Volume	140
Issue number	5
DOIs	https://doi.org/10.1309/AJCPJTWK07FSABRJ
State	Published - Nov 2013

Keywords

B-cell clonality
B-cell lymphoma
BRISH
CISH
In situ hybridization
RNAscope

ASJC Scopus subject areas

Pathology and Forensic Medicine

Access to Document

10.1309/AJCPJTWK07FSABRJ

Cite this

Tubbs, R. R., Wang, H., Wang, Z., Minca, E. C., Portier, B. P., Gruver, A. M., Lanigan, C., Luo, Y., Cook, J. R., & Ma, X. J. (2013). Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders. American Journal of Clinical Pathology, 140(5), 736-746. https://doi.org/10.1309/AJCPJTWK07FSABRJ

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders. / Tubbs, Raymond R.; Wang, Hongwei; Wang, Zhen et al.
In: American Journal of Clinical Pathology, Vol. 140, No. 5, 11.2013, p. 736-746.

Research output: Contribution to journal › Article › peer-review

Tubbs, RR, Wang, H, Wang, Z, Minca, EC, Portier, BP, Gruver, AM, Lanigan, C, Luo, Y, Cook, JR & Ma, XJ 2013, 'Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders', American Journal of Clinical Pathology, vol. 140, no. 5, pp. 736-746. https://doi.org/10.1309/AJCPJTWK07FSABRJ

@article{808940daff8d4873b4b7915892baed77,

title = "Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders",

abstract = "Objectives: To assess the feasibility of using a novel ultrasensitive bright-field in situ hybridization approach (BRISH) to evaluate k and l immunoglobulin messenger RNA (mRNA) expression in situ in B-cell non-Hodgkin lymphoma (NHL). Methods: A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH. Results: BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated. Conclusions: BRISH analysis of k and l immunoglobulin mRNA expression is a sensitive tool for establishing LCR in B-cell NHL when FCM results are not available.",

keywords = "B-cell clonality, B-cell lymphoma, BRISH, CISH, In situ hybridization, RNAscope",

author = "Tubbs, {Raymond R.} and Hongwei Wang and Zhen Wang and Minca, {Eugen C.} and Portier, {Bryce P.} and Gruver, {Aaron M.} and Christopher Lanigan and Yuling Luo and Cook, {James R.} and Ma, {Xiao Jun}",

year = "2013",

month = nov,

doi = "10.1309/AJCPJTWK07FSABRJ",

language = "English (US)",

volume = "140",

pages = "736--746",

journal = "American Journal of Clinical Pathology",

issn = "0002-9173",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

AU - Tubbs, Raymond R.

AU - Wang, Hongwei

AU - Wang, Zhen

AU - Minca, Eugen C.

AU - Portier, Bryce P.

AU - Gruver, Aaron M.

AU - Lanigan, Christopher

AU - Luo, Yuling

AU - Cook, James R.

AU - Ma, Xiao Jun

PY - 2013/11

Y1 - 2013/11

N2 - Objectives: To assess the feasibility of using a novel ultrasensitive bright-field in situ hybridization approach (BRISH) to evaluate k and l immunoglobulin messenger RNA (mRNA) expression in situ in B-cell non-Hodgkin lymphoma (NHL). Methods: A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH. Results: BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated. Conclusions: BRISH analysis of k and l immunoglobulin mRNA expression is a sensitive tool for establishing LCR in B-cell NHL when FCM results are not available.

AB - Objectives: To assess the feasibility of using a novel ultrasensitive bright-field in situ hybridization approach (BRISH) to evaluate k and l immunoglobulin messenger RNA (mRNA) expression in situ in B-cell non-Hodgkin lymphoma (NHL). Methods: A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH. Results: BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated. Conclusions: BRISH analysis of k and l immunoglobulin mRNA expression is a sensitive tool for establishing LCR in B-cell NHL when FCM results are not available.

KW - B-cell clonality

KW - B-cell lymphoma

KW - BRISH

KW - CISH

KW - In situ hybridization

KW - RNAscope

UR - http://www.scopus.com/inward/record.url?scp=84886310101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886310101&partnerID=8YFLogxK

U2 - 10.1309/AJCPJTWK07FSABRJ

DO - 10.1309/AJCPJTWK07FSABRJ

M3 - Article

C2 - 24124155

AN - SCOPUS:84886310101

SN - 0002-9173

VL - 140

SP - 736

EP - 746

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

IS - 5

ER -

Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this